NOTICE: This Consumer Medicine Information (CMI) is intended for persons
Read moreAPO-Simvastatin
Novel treatment avenue for resistant cancers: Removing SORLA protein from drug-resistant HER2-positive cancer cell lines
SORLA is a protein trafficking receptor that has been mainly
Read moreU.S. Food and Drug Administration Approves Opdivo (nivolumab) in Combination with Cabometyx (cabozantinib) as First-line Treatment for Patients with Advanced Renal Cell Carcinoma
PRINCETON, N.J.–(BUSINESS WIRE) January 22, 2021– Bristol Myers Squibb (NYSE:
Read moreScientists create ON-OFF switches to control CAR T cell activity
Scientists at Dana-Farber Cancer Institute and Mass General Cancer Center
Read moreObesity impairs immune cell function, accelerates tumor growth
Obesity has been linked to increased risk for over a
Read moreMerck Presents Three-Year Survival Data for Keytruda (pembrolizumab) in Combination With Chemotherapy and Updated Phase 1/2 Data for Investigational Quavonlimab (MK-1308) in Combination With Keytruda in Advanced Non‑Small Cell Lung Cancer
KENILWORTH, N.J.–(BUSINESS WIRE) October 16, 2020 — Merck (NYSE: MRK),
Read moreA new cell and gene therapy approach to treat common bleeding disorder
In a new study from the Wake Forest Institute for
Read moreToxic air pollution nanoparticles found in heart cell ‘powerhouses’ of city dwellers
Toxic metallic air pollution nanoparticles are getting inside the crucial,
Read morePlatform precisely quantifies antigens presented on cell surfaces
Normally, the immune system is able to differentiate between healthy
Read moreTargeted therapy with tepotinib for non-small cell lung cancer with MET exon 14 skipping mutation shows durable response
Patients with advanced non-small cell lung cancer (NSCLC) and the
Read more